Evidence map›Paper›PMID 37755161›Full record

ArticleMedical sciences (Basel, Switzerland)2023

The Anti-Inflammatory Action of Pulsed Radiofrequency-A Hypothesis and Potential Applications.

Menno E Sluijter, Alexandre Teixeira, Kris Vissers, Luis Josino Brasil, Bert van Duijn

Open access · goldAbstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Menno E SluijterPain Medicine Center, Swiss Paraplegic Center, Guido A. Zäch-Strasse 1, 6207 Nottwil, Switzerland.
Alexandre TeixeiraClinica de Dor, R. São João de Brito 610, 4100-455 Porto, Portugal.
Kris VissersDepartment of Anesthesiology and Palliative Care, Radboud Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-2919-6356
Luis Josino BrasilDepartment of Anesthesiology and Pain Medicine, University of Porto Alegre, Porto Alegre 90050-170, Brazil.
Bert van DuijnPBDL, Institute Biology, Leiden University and Fytagoras BV, Sylviusweg 72, 2333 BE Leiden, The Netherlands.ORCID 0000-0003-0304-5485
Hospital de Clínicas de Porto Alegre · BRLeiden University · NLRadboud University Nijmegen · NLSwiss Paraplegic Center · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2013, it was reported that pulsed radiofrequency (PRF) could be applied to obtain a systemic anti-inflammatory effect. Patients with chronic pain and patients with an inflammatory condition from other disciplines could potentially profit from this finding. At that time, intravenous application was used, but since then, it became clear that it could be applied transcutaneously as well. This procedure was named RedoxPRF. This can be used both for regional and for systemic application. Recently, the basic element of the mode of action has been clarified from the analysis of the effects of PRF on a standard model of muscle injury in rats. The objective of this paper is to present a hypothesis on the mode of action of RedoxPRF now that the basic mechanism has become known. Cell stress causes an increased production of free radicals, disturbing the redox equilibrium, causing oxidative stress (OS) either directly or secondarily by other types of stress. Eventually, OS causes inflammation and an increased sympathetic (nervous) system activity. In the acute form, this leads to immune paralysis; in the chronic form, to immune tolerance and chronic inflammation. It is hypothesized that RedoxPRF causes a reduction of free radicals by a recombination of radical pairs. For systemic application, the target cells are the intravascular immune cells that pass through an activated area as on an assembly line. Hypothesis conclusions: 1. RedoxPRF treatment works selectively on OS. It has the unique position of having a point of engagement at the most upstream level of the train of events. 2. RedoxPRF has the potential of being a useful tool in the treatment of inflammatory diseases and possibly of stage 4 cancer. 3. In the treatment of chronic pain, RedoxPRF is an entirely new method because it is different from ablation as well as from stimulation. We propose the term "functional restoration". 4. Controlled studies must be conducted to develop this promising new field in medicine further.

Indexed as

Chronic PainMedicinePulsed Radiofrequency TreatmentAnimalsAnti-Inflammatory AgentsHumansInflammationRatsAnti-Inflammatory Agentsage-related macular degenerationchronic kidney diseaseCOPDinflammatory diseasesmajor depressive disorderoxidative stresspulsed radiofrequencyredox equilibriumRedoxPRFstroke

Identifiers

PMID37755161
PMCPMC10536902
OpenAlexW4386619387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.